Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Inefficient vascular supply and the resultant reduction in tissue oxygen tension often lead to neovascularization in order to satisfy the needs of the tissue. Examples include the compensatory development of collateral blood vessels in ischaemic tissues that are otherwise quiescent for angiogenesis and angiogenesis associated with the healing of hypoxic wounds. But the presumptive hypoxia-induced angiogenic factors that mediate this feedback response have not been identified. Here we show that vascular endothelial growth factor (VEGF; also known as vascular permeability factor) probably functions as a hypoxia-inducible angiogenic factor. VEGF messenger RNA levels are dramatically increased within a few hours of exposing different cell cultures to hypoxia and return to background when normal oxygen supply is resumed. In situ analysis of tumour specimens undergoing neovascularization show that the production of VEGF is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci (presumably hypoxic regions) and the clustering of capillaries alongside VEGF-producing cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cells grown under hypoxic conditions activate transcription of vascular endothelial growth factor (VEGF) (Shweiki et al., 1992;Forsythe et al., 1996), which is important for endothelial cell activation and proliferation.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Shweiki et al., 1992
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Differentiated Rat Glial Cell Strain in Tissue Culture
Benda, P., Lightbody, J., Sato, G., Levine, L., & Sweet, W. (1968) · Science · doi:10.1126/science.161.3839.370 · Cited by 1,472
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60946-x · Cited by 1,071
Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., & Klagsbrun, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2292 · Cited by 1,032
Research works printed but not linked: 2
- Adair, T. A., Gay, W. J. & Montani, J.-P. Am. J. Physiol. 259, R393–R404 (1990).
- Knighton, D., Schumerth, S. & Fiegel, V. in Current Communications in Molecular Biology (eds Rifkin, D. B. & Klagsbrun, M.) 150–154 (Cold Spring Harbor Laboratory Press, New York, 1987).
Cited by
Items 201–300 of 1,033
Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M., & Honda, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15732 · Cited by 499
MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
Liu, L.-Z., Li, C., Chen, Q., Jing, Y., Carpenter, R., Jiang, Y., Kung, H.-F., Lai, L., & Jiang, B.-H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019139 · Cited by 493
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G., & Livingston, D. M. (2000) · Nature Medicine · doi:10.1038/82146 · Cited by 501
Mazure, N. M., Chen, E. Y., Laderoute, K. R., & Giaccia, A. J. (1997) · Blood · doi:10.1182/blood.v90.9.3322 · Cited by 503
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells
Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., & Isner, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31189 · Cited by 492
Stratmann, A., Risau, W., & Plate, K. H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65733-1 · Cited by 485
The Intersection between Tumor Angiogenesis and Immune Suppression
Rahma, O. E., & Hodi, F. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1543 · Cited by 472
Zhang, Y., Deng, Y., Luther, T., Müller, M., Ziegler, R., Waldherr, R., Stern, D. M., & Nawroth, P. P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117451 · Cited by 481
The Hypoxic Response: Huffing and HIFing
Guillemin, K., & Krasnow, M. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80176-2 · Cited by 478
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Abedi, H., & Zachary, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15442 · Cited by 471
Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., & Dvorak, H. F. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_10 · Cited by 472
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
Arbiser, J. L., Moses, M. A., Fernandez, C. A., Ghiso, N., Cao, Y., Klauber, N., Frank, D., Brownlee, M., Flynn, E., Parangi, S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.861 · Cited by 469
Lee, P., Wang, C. C., & Adamis, A. P. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(98)00035-6 · Cited by 464
Current concepts and management of glioblastoma
Preusser, M., de Ribaupierre, S., Wöhrer, A., Erridge, S. C., Hegi, M., Weller, M., & Stupp, R. (2011) · Annals of Neurology · doi:10.1002/ana.22425 · Cited by 461
Hypoxic gene expression and metastasis
Le, Q.-T., Denko, N. C., & Giaccia, A. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031768.89246.d7 · Cited by 468
Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., & Risau, W. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590415 · Cited by 463
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
HEBBEL, R. P., OSAROGIAGBON, R., & KAUL, D. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 463
Takano, H., Morita, T., Iida, H., Asada, K.-I., Kato, M., Uno, K., Hirose, K., Matsumoto, A., Takenaka, K., Hirata, Y., et al. (2005) · European Journal of Applied Physiology · doi:10.1007/s00421-005-1389-1 · Cited by 445
Stein, I., Neeman, M., Shweiki, D., Itin, A., & Keshet, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5363 · Cited by 455
Self-citationTargeted Therapy for Metastatic Renal Cell Carcinoma
Motzer, R. J., & Bukowski, R. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5415 · Cited by 454
Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells
Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K., & Kuwano, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28220 · Cited by 454
Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., & Gutkind, J. S. (2000) · PubMed · Cited by 516
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Vasculogenesis and Angiogenesis
Patan, S. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_1 · Cited by 430
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Phung, T. L., Ziv, K., Dabydeen, D., Eyiah-Mensah, G., Riveros, M., Perruzzi, C., Sun, J., Monahan-Earley, R. A., Shiojima, I., Nagy, J. A., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.003 · Cited by 438
Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8795 · Cited by 443
Stephen Charnock-Jones, D., Sharkey, A. M., Rajput-Williams, J., Burch, D., Paul Schofield, J., Fountain, S. A., Boocock, C. A., & Smith, S. K. (1993) · Biology of Reproduction · doi:10.1095/biolreprod48.5.1120 · Cited by 445
Endothelial dysfunction and pathogenesis of diabetic angiopathy
Stehouwer, C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00272-6 · Cited by 441
VEGF is major stimulator in model of choroidal neovascularization.
Kwak, N., Okamoto, N., Wood, J. M., & Campochiaro, P. A. (2000) · PubMed · Cited by 442
Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain
Schoch, H. J. (2002) · Brain · doi:10.1093/brain/awf257 · Cited by 433
Bachelder, R. E., Crago, A. M., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G. S., & Mercurio, A. M. (2001) · PubMed · Cited by 487
Kryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421
Telomerase in human development and cancer
Shay, J. W. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<266::aid-jcp33>3.0.co;2-b · Cited by 141
Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7128 · Cited by 432
NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and Pathophysiology
Frey, R. S., Ushio–Fukai, M., & Malik, A. B. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2220 · Cited by 420
Kroll, J., & Waltenberger, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32521 · Cited by 430
Activation of the HIF pathway in cancer
Maxwell, P. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
Darash-Yahana, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0935fje · Cited by 421
Hypoxia-driven selection of the metastatic phenotype
Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 410
Kuroki, M., Voest, E. E., Amano, S., Beerepoot, L. V., Takashima, S., Tolentino, M., Kim, R. Y., Rohan, R. M., Colby, K. A., Yeo, K. T., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118962 · Cited by 423
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas
Fine, H. A., Figg, W. D., Jaeckle, K., Wen, P. Y., Kyritsis, A. P., Loeffler, J. S., Levin, V. A., Black, P. M., Kaplan, R., Pluda, J. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.708 · Cited by 423
Kotch, L. E., Iyer, N. V., Laughner, E., & Semenza, G. L. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9253 · Cited by 418
Molecular mechanisms of vasculogenesis and embryonic angiogenesis
Flamme, I., Frölich, T., & Risau, W. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<206::aid-jcp22>3.0.co;2-c · Cited by 421
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Li, I., & Nabet, B. Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0975-5 · Cited by 416
(1996) · PubMed · Cited by 415
The role of vascular endothelial growth factor in pathological angiogenesis
Ferrara, N. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666035 · Cited by 414
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., & Strawn, L. M. (1996) · PubMed · Cited by 413
Marti, H. H., & Risau, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15809 · Cited by 411
Vascular endothelial growth factor in the lung
Voelkel, N. F., Vandivier, R. W., & Tuder, R. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00185.2005 · Cited by 403
Leker, R. R., & Shohami, E. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00157-1 · Cited by 409
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
Spilsbury, K., Garrett, K. L., Shen, W.-Y., Constable, I. J., & Rakoczy, P. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64525-7 · Cited by 394
Provenzale, J. M., Mukundan, S., & Barboriak, D. P. (2006) · Radiology · doi:10.1148/radiol.2393042031 · Cited by 402
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Ziche, M., & Morbidelli, L. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006431309841 · Cited by 386
Expression of vascular endothelial growth factor in human hepatocellular carcinoma
Yamaguchi, R., Yano, H., Iemura, A., Ogasawara, S., Haramaki, M., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510280111 · Cited by 397
Multiple Molecular Penumbras after Focal Cerebral Ischemia
Sharp, F. R., Lu, A., Tang, Y., & Millhorn, D. E. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00001 · Cited by 403
Stavri, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., & Erusalimsky, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.1.11 · Cited by 395
Vasculogenesis and Angiogenesis as Mechanisms of Vascular Network Formation, Growth and Remodeling
Patan, S. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006493130855 · Cited by 382
Campochiaro, P. A. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0993-5 · Cited by 386
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391
The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.
Oh, H., Takagi, H., Takagi, C., Suzuma, K., Otani, A., Ishida, K., Matsumura, M., Ogura, Y., & Honda, Y. (1999) · PubMed · Cited by 393
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene
Drissi, H., Luc, Q., Shakoori, R., Chuva De Sousa Lopes, S., Choi, J.-Y., Terry, A., Hu, M., Jones, S., Neil, J. C., Lian, J. B., et al. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<341::aid-jcp8>3.0.co;2-z · Cited by 247
Retinal and choroidal neovascularization
Campochiaro, P. A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<301::aid-jcp3>3.0.co;2-h · Cited by 393
Principals of neovascularization for tissue engineering
Nomi, M., Atala, A., Coppi, P. D., & Soker, S. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00008-0 · Cited by 392
Intracellular signaling mechanisms in photodynamic therapy
Almeida, R. D., Manadas, B. J., Carvalho, A. P., & Duarte, C. B. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.05.003 · Cited by 379
Chen, W., Delaloye, S., Silverman, D. H. S., Geist, C., Czernin, J., Sayre, J., Satyamurthy, N., Pope, W., Lai, A., Phelps, M. E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5825 · Cited by 393
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Allen, M., & Louise Jones, J. (2011) · The Journal of Pathology · doi:10.1002/path.2803 · Cited by 375
Colavitti, R., Pani, G., Bedogni, B., Anzevino, R., Borrello, S., Waltenberger, J., & Galeotti, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107711200 · Cited by 384
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
Mandriota, S. J., & Pepper, M. S. (1998) · Circulation Research · doi:10.1161/01.res.83.8.852 · Cited by 381
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
Biological consequences of tumor hypoxia
HOCKEL, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90211-8 · Cited by 382
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
Finger, E. C., & Giaccia, A. J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9224-5 · Cited by 370
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Corbı́, A., Attisano, L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104536200 · Cited by 380
A systems view of the vascular endothelium in health and disease
Augustin, H. G., & Koh, G. Y. (2024) · Cell · doi:10.1016/j.cell.2024.07.012 · Cited by 343
Schänzer, A., Wachs, F., Wilhelm, D., Acker, T., Cooper‐Kuhn, C., Beck, H., Winkler, J., Aigner, L., Plate, K. H., & Kuhn, H. G. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00060.x · Cited by 364
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208513 · Cited by 372
Imai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., Nikaido, T., & Konishi, I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63501-8 · Cited by 377
The vasculature and its role in the damaged and healing tendon.
Fenwick, S., Hazleman, B. L., & Riley, G. P. (2002) · Arthritis Research · doi:10.1186/ar416 · Cited by 376
Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374
Self-citationFlamme, I., Fröhlich, T., von Reutern, M., Kappel, A., Damert, A., & Risau, W. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00674-6 · Cited by 366
Newest findings on the oldest oncogene; how activated src does it
Frame, M. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01111 · Cited by 367
ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESS
Faller, D. V. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.02992.x · Cited by 372
Molecular Mechanisms of Coronary Collateral Vessel Growth
Schaper, W., & Ito, W. D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.911 · Cited by 371
Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function
Williams, C. K., Li, J.-L., Murga, M., Harris, A. L., & Tosato, G. (2006) · Blood · doi:10.1182/blood-2005-03-1000 · Cited by 360
Immunosuppressive mechanisms in glioblastoma: Fig. 1.
Nduom, E. K., Weller, M., & Heimberger, A. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov151 · Cited by 348
Oxygen Sensing, Hypoxia-Inducible Factor-1 and the Regulation of Mammalian Gene Expression
Ratcliffe, P. J., O’rourke, J. F., Maxwell, P. H., & Pugh, C. W. (1998) · Journal of Experimental Biology · doi:10.1242/jeb.201.8.1153 · Cited by 371
FRANK, R. N., AMIN, R. H., ELIOTT, D., PUKLIN, J. E., & ABRAMS, G. W. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)72066-5 · Cited by 366
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
Gnarra, J. R., Ward, J. M., Porter, F. D., Wagner, J. R., Devor, D. E., Grinberg, A., Emmert-Buck, M. R., Westphal, H., Klausner, R. D., & Linehan, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9102 · Cited by 362
Biopolymeric delivery matrices for angiogenic growth factors
Zisch, A. H., Lutolf, M. P., & Hubbell, J. A. (2003) · Cardiovascular Pathology · doi:10.1016/s1054-8807(03)00089-9 · Cited by 357
Extracranial Arteriovenous Malformations: Natural Progression and Recurrence after Treatment
Liu, A. S., Mulliken, J. B., Zurakowski, D., Fishman, S. J., & Greene, A. K. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181d18070 · Cited by 364
Tissue homeostasis and inflammation
Meizlish, M. L., Franklin, R. A., Zhou, X., & Medzhitov, R. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-061020-053734 · Cited by 364
Gustafsson, T., Puntschart, A., Kaijser, L., Jansson, E., & Sundberg, C. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.2.h679 · Cited by 367
Metadata
- Authors
- Shweiki, D., Itin, A., Soffer, D., & Keshet, E.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- Nature
- Published
- 1992-10
- Volume
- 359
- Issue
- 6398
- Pages
- 843-845
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015344488
- Cited by
- 4,617
- References
- 28
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 70 · 2023: 70 · 2022: 89 · 2021: 90 · 2020: 94 · 2019: 98 · 2018: 81 · 2017: 83 · 2016: 114 · 2015: 104 · 2014: 128 · 2013: 137 · 2012: 141
- FWCI
- 29.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, hypoxia, angiogenesis, neovascularization, glioblastoma, tumor necrosis, tumor hypoxia, tumor vasculature
- MeSH terms
- Animals, Brain Neoplasms, Cell Division, Endothelium, Vascular, Glioblastoma, Humans, Lymphokines, Necrosis, Neovascularization, Pathologic, RNA, Messenger, RNA, Neoplasm, Tumor Cells, Cultured, Cell Hypoxia, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.